Skip to content

Board of Directors

  • Neal Fowler, Pathalys Pharma, Board Chairman
  • Tom Adams, Pairwise
  • Daniel Amburn, UCB
  • Sinu Bhandaru, Precision BioSciences
  • Chuck Blatchley, Grifols
  • Matt Boyer, Pappas Capital
  • Julie Broadus Meigs, Womble Bond Dickinson
  • Christopher Capel, Smith Anderson
  • Matthew Cooke, Davis Moore
  • Lisa Davidson, Syneos Health
  • Bill Edwards, Merz Aesthetics
  • Sholeh Ehdaivand, LMK Clinical Research Consulting
  • Mike Elder, Novozymes
  • Tom Fagley, Hughes Pittman & Gupton
  • Maeve Gardner, GlaxoSmithKline
  • Alex Graham, Thermo Fisher Scientific/Patheon
  • Toni Lockett Cromwell, PricewaterhouseCoopers
  • Bennett Love, BioKier
  • Mike McBrierty, Biogen
  • Sheila Mikhail, AskBio
  • John Mikszta, BD
  • Russ Read, National Center for Biotechnology Workforce
  • Joe Ruiz, Enzerna Biosciences
  • Marlene Sanders, Merck & Co.
  • Scott Sewell, Cook Medical
  • Peter Shaw, Bioventus
  • Gary Shope, Patheon
  • Kseniya Simpson, Hatteras Venture Partners
  • Blake Stevens, Alexandria Real Estate Equities
  • Susan Thomason, IQVIA
  • Jon Tucker, Pfizer
  • Christine Vannais, Fujifilm Diosynth
  • Tim Willis, MED1 Ventures
  • Peter Wirth, RTI International